AaiPharma.

PositionEastern - Brief Article

WILMINGTON -- AaiPharma's founder and chairman returned to his CEO role after disclosure that the drug maker had hired Atlanta-based law firm King & Spalding to investigate sales irregularities involving its top products, the asthma drug Brethine and painkiller Darvocet. Frederick Sancilio replaced Philip Tabbiner. The company would delay its 2003 annual...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT